Keyphrases
Atrophic Gastritis
29%
CagA
14%
Chronic Gastritis
16%
Chronic Hepatitis
21%
Chronic Hepatitis B Patients
40%
Chronic Liver Disease
31%
Core Needle Biopsy
19%
COVID-19
53%
COVID-19 Patients
43%
D-dimer
14%
Diagnostic Value
29%
Dyspepsia
37%
Ethnic Groups
18%
Fecal Calprotectin
36%
Fibrosis
18%
Gastric mucosal
24%
Gastritis
19%
Gastroesophageal Reflux Disease
20%
General Hospital
17%
Helicobacter Pylori (H. pylori)
100%
Helicobacter Pylori Infection
58%
Hepatic Hydrothorax
19%
Hepatitis B
24%
Hepatitis B Virus X Gene
14%
Hepatocellular Carcinoma
23%
Hepatocellular Carcinoma Patients
19%
Indonesia
87%
Indonesian
25%
Infected Patients
14%
Infection Rate
15%
Interleukin-6
24%
Interleukin-6 Expression
19%
Liver
19%
Liver Biopsy
14%
Liver Cirrhosis
23%
Liver Fibrosis
21%
Liver Function
23%
Low Prevalence
17%
Lung Tissue
19%
Meta-analysis
30%
Odds Ratio
14%
Pepsinogen
20%
Proton Pump Inhibitors
17%
Surabaya
38%
Systematic Meta-analysis
19%
Transarterial Chemoembolization
19%
Transient Elastography
21%
Urea Breath Test
17%
Viral Load
19%
X Gene mutation
15%
Medicine and Dentistry
Abdominal Cancer
19%
Atrophic Gastritis
22%
Bilirubin
15%
Biological Marker
21%
Biopsy Technique
21%
Cancer
13%
Cancer Screening
11%
Carbon 14
11%
Chronic Gastritis
13%
Chronic Hepatitis B
16%
Chronic Liver Disease
21%
COVID-19
68%
Diagnosis
22%
Digestive System Inflammation
11%
Ethnic Group
16%
Faecal Calprotectin
19%
Gastritis
17%
Gastroesophageal Reflux
10%
Helicobacter Infection
22%
Helicobacter Pylori
84%
Hepatitis B
13%
Hepatitis B Antigen
13%
Hepatitis B Virus
13%
Hepatitis B(e) Antigen
13%
Hepatocellular Carcinoma
19%
Histopathology
21%
Hydrothorax
19%
Hypoxemia
11%
Infection
28%
Interleukin 6
19%
Liver Biopsy
11%
Liver Cirrhosis
33%
Liver Fibrosis
11%
Liver Function
13%
Liver Injury
22%
Liver Transplantation
11%
Meta-Analysis
10%
Odds Ratio
11%
Overall Survival
9%
Patient with Obesity
9%
Pepsinogen
16%
Pepsinogen I
10%
Pleura Effusion
11%
Prevalence
22%
Proton-Pump Inhibitor
14%
Pylorus
9%
Stomach Acid
28%
Transcatheter Arterial Chemoembolization
19%
Transient Elastography
15%
Urea Breath Test
17%
Pharmacology, Toxicology and Pharmaceutical Science
Adult Respiratory Distress Syndrome
10%
Antivirus Agent
9%
Atrophic Gastritis
8%
Binding Protein
9%
Biological Marker
11%
C Reactive Protein
9%
Calgranulin
39%
Chronic Hepatitis
21%
Chronic Hepatitis B
43%
Chronic Hepatitis C
8%
Chronic Liver Disease
29%
Colitis
9%
Colorectal Carcinoma
9%
Coronavirinae
39%
Digestive System Inflammation
11%
Disease Activity
9%
Diseases
42%
Fibrosis
21%
Gastrin 17
9%
Gastritis
15%
Gastroesophageal Reflux
10%
Helicobacter Infection
30%
Helicobacter Pylori
65%
Hepatitis B
13%
Hepatitis B Antigen
24%
Hepatitis B Virus
38%
Hepatitis B(e) Antigen
18%
Infection
28%
Inflammation
10%
Insulin Resistance
11%
Interleukin 10
9%
Interleukin 17
9%
Interleukin 6
39%
Interleukin 8
9%
Intestine Injury
9%
Lamivudine
9%
Liver Cell Carcinoma
20%
Liver Fibrosis
21%
Liver Injury
22%
Metformin
9%
Metronidazole
9%
Prevalence
18%
Protein P53
9%
Proton Pump Inhibitor
11%
Retrospective Study
9%
Spondylarthritis
9%
Stomach Acid
34%
Telbivudine
9%
Tumor Necrosis Factor
19%
Urease
9%